Early Phase 1 Gliomas Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
Gliomas
M.D. Anderson Cancer Center40 enrolled1 locationNCT05804227
Recruiting
Early Phase 1
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
Adult Gliomas, Mixed
Robert Bok, MD, PhD40 enrolled1 locationNCT05851378
Recruiting
Early Phase 1
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
Gliomas
JIANG LONGWEI3 enrolled1 locationNCT06828341